Abernethy Melinda G, Rosenfeld Amy, White James R, Mueller Margaret G, Lewicky-Gaupp Christina, Kenton Kimberly
Northwestern Feinberg School of Medicine, Chicago, Illinois; Columbia University, New York, New York; and Resphera Biosciences, Baltimore, Maryland.
Obstet Gynecol. 2017 Mar;129(3):500-506. doi: 10.1097/AOG.0000000000001892.
To investigate differences in the urinary microbiome and cytokine levels between women with and without interstitial cystitis and to correlate differences with scores on standardized symptom severity scales and depression and anxiety screening tools.
Our cross-sectional study compared women presenting to a pelvic floor clinic and diagnosed with interstitial cystitis over a 6-month period with age-matched women in a control group from the same institution. Participants provided a catheterized urine sample and completed symptom severity, quality-of-life, depression, and anxiety screening questionnaires. Urinary microbiomes generated through bacterial ribosomal RNA sequencing and cytokine levels were analyzed using a standard immunoassay. Nonparametric analyses were used for all comparisons.
Participants with interstitial cystitis reported more disability, bothersome urinary symptoms, genitourinary pain, and sexual dysfunction and scored higher on depression and anxiety screens compared with women in the control group. The urine of participants with interstitial cystitis contained fewer distinct operational taxonomic units (2 [median range 2-7, interquartile range 1] compared with 3.5 [median, range 2-22, interquartile range 5.25], P=.015) and was less likely to contain Lactobacillus acidophilus (1/14 [7%] compared with 7/18 [39%], P=.05) compared with women in the control group. L acidophilus was associated with less severe scores on the Interstitial Cystitis Symptoms Index (1 [median, range 0-17, interquartile range 5] compared with 10 [median, range 0-14, interquartile range 11], P=.005) and the Genitourinary Pain Index (0 [median, range 0-42, interquartile range 22] compared with 22.5 [median, range 0-40, interquartile range 28], P=.03). Participants with interstitial cystitis demonstrated higher levels of macrophage-derived chemokine (13.32 [median, range 8.93-17.05, interquartile range 15.86] compared with 0 [median, range 8.93-22.67, interquartile range 10.35], P=.037) and interleukin-4 (1.95 [median, range 1.31-997, interquartile range 11.84] compared with 1.17 [median, range 0.44-3.26, interquartile range 1.51], P=.029). There was a positive correlation between interleukin-4 and more severe scores on the Interstitial Cystitis Symptoms Index (r=0.406, P=.013). No associations between the presence of lactobacillus species and cytokine levels were observed.
The urinary microbiome of participants with interstitial cystitis was less diverse, less likely to contain Lactobacillus species, and associated with higher levels of proinflammatory cytokines. It is unknown whether this represents causality and whether the effect of alterations to the urinary microbiome is mediated through an inflammatory response.
研究间质性膀胱炎女性与非间质性膀胱炎女性的尿液微生物群和细胞因子水平差异,并将这些差异与标准化症状严重程度量表以及抑郁和焦虑筛查工具的评分相关联。
我们的横断面研究将在6个月内到盆底诊所就诊并被诊断为间质性膀胱炎的女性与来自同一机构的年龄匹配的对照组女性进行了比较。参与者提供了导尿尿液样本,并完成了症状严重程度、生活质量、抑郁和焦虑筛查问卷。使用细菌核糖体RNA测序生成尿液微生物群,并使用标准免疫测定法分析细胞因子水平。所有比较均采用非参数分析。
与对照组女性相比,间质性膀胱炎参与者报告了更多的功能障碍、令人烦恼的泌尿系统症状、泌尿生殖系统疼痛和性功能障碍,并且在抑郁和焦虑筛查中的得分更高。间质性膀胱炎参与者的尿液中独特的可操作分类单元较少(2个[中位数范围2 - 7,四分位间距1],而对照组为3.5个[中位数,范围2 - 22,四分位间距5.25],P = 0.015),并且与对照组女性相比,含有嗜酸乳杆菌的可能性较小(1/14 [7%],而对照组为7/18 [39%],P = 0.05)。嗜酸乳杆菌与间质性膀胱炎症状指数得分较低相关(1 [中位数,范围0 - 17,四分位间距5],而对照组为10 [中位数,范围0 - 14,四分位间距11]),P = 0.005)以及泌尿生殖系统疼痛指数得分较低相关(0 [中位数,范围0 - 42,四分位间距22],而对照组为22.5 [中位数,范围0 - 四十,四分位间距28],P = 0.03)。间质性膀胱炎参与者表现出较高水平的巨噬细胞衍生趋化因子(13.32 [中位数,范围8.93 - 17.05,四分位间距15.86],而对照组为0 [中位数,范围8.93 - 22.67,四分位间距10.35],P = 0.037)和白细胞介素-4(1.95 [中位数,范围1.31 - 997,四分位间距11.84],而对照组为1.17 [中位数,范围0.44 - 3.26,四分位间距1.51],P = 0.029)。白细胞介素-4与间质性膀胱炎症状指数得分更高之间存在正相关(r = 0.406,P = 0.013)。未观察到乳杆菌属的存在与细胞因子水平之间的关联。
间质性膀胱炎参与者的尿液微生物群多样性较低,含有乳杆菌属的可能性较小,并且与促炎细胞因子水平较高相关。尚不清楚这是否代表因果关系,以及尿液微生物群改变的影响是否通过炎症反应介导。